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Introduction
Since the discovery of the anticancer properties of cisplatin, carboplatin and oxaliplatin, metal-based drugs have been recognized as very promising agents capable of revolutionizing cancer therapy (Jakupec et al. 2008; Quiroga 2012; Muggia 2009; Jamieson and Lippard 1999) . Following the success of these compounds, a large number of structurally similar compounds have been synthesized in the attempt to discover more effective anti-tumor drugs. During the last two decades, several non-platinum complexes based on ruthenium, gold, palladium or titanium with structures that are not directly related to platinumbased drugs have been evaluated as potential anticancer drugs (Cutillas et al. 2013; Gasser et al. 2011) . Furthermore, significant antitumor activity with a lower systemic toxicity than cisplatin has been described in the literature for several palladium(II) complexes (Rocha et al. 2010; Gao et al. 2010; Trevisan et al. 2002) . Coordination chemistry of polypyridyl ligands attracts widespread interest based on the wide range of applications for the resulting metal complexes. In the field of biology and medicine these complexes are particularly investigated as photocleavage agents for DNA, as complexes with promising cytotoxic effect and for their luminescence properties (Indumathy et al. 2007; Zhang et al. 2001) . Among them, complexes with general formula [M(terpy) 2 ] n? or [M(terpy)X m ] n? (where M = a dblock element, such as ruthenium(II) or osmium(II), terpy = terpyridine, (un)substituted 2,6-bis(2-pyridyl)pyridine and X = halide/pseudo halide) are very interesting for their electrochemical, catalytic and optical properties (Naseri et al. 2012; Yeung et al. 2010; Sauvage et al. 1994) . Terpy and its derivatives are well-established ligands for transition metals, especially those with d 8 configuration, which form square-planar complexes (Hollis and Lippard 1983; Jennette et al. 1976; Lippard 1978 (Fig. 1, compound a) showed strong anti-cancer activity against breast cancer cells, inducing apoptosis. Moreover, these complexes are able to significantly reduce tumor growth in vivo (Ulukaya et al. 2011) . The introduction of structural modification on the terpy molecule, especially at the 4 0 position, generates various substituted terpy ligands, affecting the antitumor activity of the resulting complexes (Kumar et al. 2011; Patel et al. 2012; Ma et al. 2010; Shi et al. 2006; Chu et al. 2013 ). It has also been shown that the substituent in the 4 0 position plays an important role in increasing the solubility of the complex and the interaction with DNA (Chu et al. 2013) . Pt(II), Pd(II), Zn(II) and Cu(II) complexes with 4 0 -substituted terpy exhibited promising cytotoxicity against several cell lines, with IC 50 values comparable or even lower than cisplatin (Fig. 1, compounds b , c, d and e) (Wang et al. 2013) . The development of new selective and sensitive bioanalytical techniques allowed to better understand the mode of action of metal-based drugs. It is common opinion that the primary target for the pharmacological effects of cisplatin is nuclear DNA. Thus, cisplatin exerts its cytotoxicity through binding of the Pt(II) center at the level of the N7 atom of adjacent guanines, resulting in 1,2 and 1,3-intrastrand or interstrand cross-links (Todd and Lippard 2010) . The binding inhibits DNA replication finally leading to apoptosis (Wang and Lippard 2005) . However, in the last decades, a number of studies have shown that metal-based drugs undergo a wide range of biomolecular interactions, with proteins being possible targets for binding too. In this view, the mode of action of ruthenium and gold compounds are still unknown and are a matter of intense research and debate. It has been reported that for some of these compounds the favored target are the proteins instead of DNA (Gasser et al. 2011; Gabbiani et al. 2012) , protein metalation being the process through which proteins are modified with metal species (often a molecular fragment derived from the starting metal complex).
The metallic fragments may interact with the proteins by a direct coordinative bond or through a non-covalent interaction, resulting in the formation of adducts between the protein and a metal species (Gabbiani et al. 2011) . Detailed characterization of the resulting metal-protein adducts, including identification of the metal fragments and the binding stoichiometry, can be achieved by electrospray ionization mass spectrometry (ESI-MS) (Merlino et al. 2017) .
In this work, we describe the preparation, characterization and the antiproliferative effects toward a representative panel of cancer cell lines of five new palladium(II) and platinum(II) complexes with different 4 0 -substituted terpy ligands of general formula: [MCl(L)]BF 4 , where M represents Pd(II) or Pt(II) and L represents the corresponding terpy ligand L1-L3, (Scheme 1). L1 and L2 have been selected to increase the solubility of desired complexes in physiological conditions, while the use of L3 as a ligand can ensure additional p-p stacking interactions and the alkylating potential after coordination to the metal center. Also, their interactions with model proteins (i.e. HEWL, cyt c and RNase A) has been investigated through ESI-MS analysis following a well-established experimental protocol (Merlino et al. 2017 ).
Materials and methods
PdCl 2 , K 2 [PtCl 4 ] and NaBF 4 were purchased from Sigma-Aldrich, while the solvents were obtained from different commercial sources and used as received. Ligands were prepared following synthetic procedures reported in literature (Sampath et al. 1999; Andres et al. 2003; Anthonysamy et al. 2008) . RNase A (from bovine pancreas R5500), cytochrome c (from equine (Wang et al. 2013) heart C7752) and hen egg wite lysozyme (HEWL) were purchased from Sigma-Aldrich and used without further purifications. Elemental analysis (C, H, N) Fig. 2 . Standard LC-MS analysis was performed on an Agilent 1100 series HPLC equipped with a quaternary pump and UV-DAD detection, directly coupled to an Agilent G1956B single quadrupole MS detector equipped with an ESI ionization source. High resolution mass spectrometry (HRMS) was performed on an Agilent 1100 series HPLC equipped with a quaternary pump and UV-DAD detector directly coupled to an Agilent 6220A series Time-of-Flight MS detector, equipped with an ESI/ APCI (multimode) ionization source. IR spectra were recorded from 4000 to 650 cm -1 , on a Thermo Scientific FT-IR spectrometer (type Nicolet 6700), using KBr as a non-absorbing matrix. ? ).
Single-crystal X-ray diffraction For the structures of 2, 3 and 5, X-ray intensity data were collected at 100 K, on an Agilent Supernova Dual Source (Cu at zero) diffractometer equipped with an Atlas CCD detector using x scans and CuKa (k = 1.54184 Å ) for 2 or MoKa (k = 0.71073 Å ) radiation for 3 and 5. The images were interpreted and integrated with the program CrysAlisPro (Rigaku Oxford Diffraction 2015). Using Olex2 (Dolomanov et al. 2009 ), the structures were solved by direct methods using the ShelXS structure solution program and refined by full-matrix least-squares on F 2 using the ShelXL program package (Sheldrick 2008 (Sheldrick , 2015 . Non-hydrogen atoms were anisotropically refined and the hydrogen atoms in the riding mode and isotropic temperature factors fixed at 1.2 times U(eq) of the parent atoms (1.5 times for hydroxyl groups). , l(Cu-Ka) = 6.108 mm -1 , F(000) = 1264, 37,298 reflections measured, 11,742 unique (R int = 0.0649) which were used in all calculations. The final R1 was 0.0468 (I [ 2r(I)) and wR2 was 0.1047 (all data). The contribution of heavily disordered solvent peaks (most probably from a diethyl ether molecule) was taken into using the SQUEEZE procedure, implemented in the program PLATON (Spek 2009 ).
In addition, ligand L2 is also characterized by X-ray analysis and the data are presented in SI (Figs. S16 and S17).
CCDC 1568867-1568870 contain the supplementary crystallographic data for this paper and can be obtained free of charge via www.ccdc.cam.ac.uk/ conts/retrieving.html (or from the Cambridge Crystallographic Data Centre, 12, Union Road, Cambridge CB2 1EZ, UK; fax: ?44-1223-336033; or deposit@ccdc.cam.ac.uk).
Spectrophotometric studies
To assess the compounds stability, spectrophotometric studies were performed using a Varian Cary 50 Bio UV-Vis spectrophotometer. Small amounts of freshly prepared concentrated solutions of the five compounds in DMSO were diluted in 20 mM ammonium acetate buffer pH 6.8, in the presence of 1% DMSO. The concentration of each compound in the final sample was 10 -5 M. The resulting solutions were monitored by collection of the electronic spectra for 72 h at room temperature in the range between 200 and 800 nm.
Interactions with biomolecules
Metal complex-protein adducts were prepared incubating for 72 h each protein (Horse heart cytochrome c, ribonuclease A from bovine pancreas and HEWL) with an excess of the complex (final protein concentration 10 -4 M, protein to metal ratio 3:1) in 20 mM ammonium acetate buffer pH 6.8, in the presence of 30% DMSO at 37°C. Electrospray ionization mass spectrometry (ESI-MS) spectra were recorded after a 20-fold dilution of the metal complex-protein sample with water. Samples were introduced at 5 lL/min flow rate in an Orbitrap high-resolution mass spectrometer (Thermo, San Jose, CA, USA), equipped with a conventional ESI source. The working conditions were the following: spray voltage 3.1 kV, capillary voltage 45 V, capillary temperature 220°C, tube lens voltage 230 V. The sheath and the auxiliary gases were set, respectively, at 17 (arbitrary units) and 1 (arbitrary units). For acquisition, Xcalibur 2.0. software (Thermo) was used and monoisotopic and average deconvoluted masses were obtained by using the integrated-Xtract tool. For spectrum acquisition, a nominal resolution (at m/z 400) of 100,000 was used.
Cellular studies

Cell cultures
A549 and HDF cell lines were cultured in DMEM High glucose (Euroclone; Milan, Italy) supplemented with 4 mM L-Glut, 10% fetal bovine serum (FBS) (Euroclone EU Approved; Euroclone; Milan, Italy) (complete medium). HCT-116, and IGROV-1 were cultured in RPMI 1640 (Euroclone; Milan, Italy) supplemented with 2 mM L-Glut, with 10% Fetal Bovine Serum (FBS) (Euroclone Defined; Euroclone; Milan, Italy) (complete medium). HCT116 cells were kindly provided by Dr R. Falcioni (Regina Elena Cancer Institute, Roma). Cells were cultured at 37°C in a humidified atmosphere in 5% CO 2 in air.
Pharmacology experiments
Cells were seeded at 1 9 10 4 /well in 96-well plates (Costar Corning) in complete medium and incubated for 24 h before drug addition. Each compound was used, after dissolving in DMSO, in a concentration range of 0-100 lM. After 24 h, viable cells, determined by a Trypan Blue exclusion test, were counted in triplicate using a haemocytometer. Each experimental point represents the mean of a single experiment carried out in triplicate. The effect of DMSO was subtracted from the effect of each compound in each experiment performed.
Trypan blue assay
Cells viability was assessed by a Trypan Blue exclusion assay. Briefly, 10 lL of 0.4% Trypan Blue solution (Fluka) was added to 10 lL cell suspensions in culture medium. The suspension was gently mixed and transferred to a haemocytometer. Viable and dead cells were identified and counted under a light microscope. Blue cells failing to exclude the dyes were considered nonviable, and transparent cells were considered viable. The number of viable cells was counted and the IC 50 value (i.e., the dose that caused a decrease in cell proliferation over control of 50%) was calculated by fitting the data points with a sigmoidal curve using Calcusyn software (Biosoft, Cambridge, UK).
Results and discussion
Synthesis and chemical characterization
The ligands L1-L3 were prepared as previously reported (Sampath et al. 1999; Andres et al. 2003; Anthonysamy et al. 2008) . Complexes 1-5 were prepared by the reaction of PdCl 2 or K 2 [PdCl 4 ] with the 4 0 -substituted terpy ligands (L1-L3) in nitromethane. All complexes were isolated from the reaction mixture as precipitates after adding diethyl ether, in the form of monocationic complexes, with tetrafluoroborate as counteranion (Scheme 1). The complexes were partially soluble in DMSO and chloroform and they showed good solubility and stability in ammonium-acetate buffer (pH 6.8-7.0; Fig. S1 ).
All the complexes were characterized by elemental analysis, UV-Vis, IR and 1 H NMR spectroscopy, ESI-MS confirming their structure. Single-crystal X-ray diffraction was performed for 2, 3 and 5.
The 1 H NMR spectra of the ligands (Fig. S2-S4 ) and corresponding complexes (Fig. S5-S9 ) were recorded in . The signals of aliphatic alkyl moiety of the 4 0 -terpy ligands are found in the range from 1.52 to 4.78 ppm. Characteristic signals at 4.74 and 4.76 ppm for complexes 1 and 4, respectively, are assigned to the proton from the OH group of ligand L1. The spectrum of the free ligand shows similar signals for OH proton, indicating that this group is not involved in coordination to the metal center. Likewise, for both complexes, 2 and 5, the protons from the carboxylic group are detected around 12 ppm, while signals of the aromatic protons in the complexes are detected in the region typical for the terpy ligand, at expected chemical shifts.
Solution behavior
UV-Vis spectral profiles of all these complexes, remain substantially unaltered in ammonium acetate buffer, also after 72 h of incubation at room temperature. Specifically, UV-Vis spectra of compounds 1 and 2 show three peaks approximately at 280, 330, and 350 nm (Fig. S1 A and B) , while compound 3 and 4 display a broad band around 290 nm, and 275 nm, respectively ( Fig. S1 C and D) . Finally, the spectrum of compound 5 shows a main peak around 280 nm with shoulders in the range between 300 and 350 nm. Overall, the compounds manifested an appreciable stability; only a slight and progressive decrease in the intensity of the absorption was detected, most probably due to slight precipitation of the complexes. Also, the conserved spectral profiles, imply that the presence of DMSO does not affect the stability and the complexes do not undergo significant structural changes (Fig. S1 ).
Single-crystal X-ray structural analysis
Compound 2 crystallized in the triclinic centrosymmetric space group P-1, with the asymmetric unit consisting of one [PdCl(L2)]
? complex cation and one BF 4 -counterion. The Pd(II) atom is four-coordinated by the nitrogen atoms of the tridentate chelating L2 ligand and a chloride ion, showing a square-planar geometry (Fig. 3) . The dihedral angle between planes through the respective outer pyridine rings N2/C6-C10 and N3/C11-C15 is only 1.8(3)°, and the dihedral angles between the outer rings and central pyridine ring N1/C1-C5 are 0.9(3)°and 1.9(3)°, respectively. The Pd-N bond distance to the central nitrogen atom [Pd1-N1 = 1.966(5) Å ] is slightly shorter than to the two outer nitrogen atoms [Pd1-N2 = 2.007(5) Å and Pd1-N3 = 2.016 (6) The carboxypentoxy chain is found completely staggered, and is almost planar with respect to the terpyridine ring system (C2-C3-O1-C16 torsion angle of -175.0(5)°). The largest deviation in torsion angle from the ideal value of 180°in the carboxypentoxy chain is -172.6(5)°for C16-C17-C18-C19.
In the crystal packing, classic hydrogen bonds are observed between the carboxyl group and a BF 4 -fluorine atom [O2(-H2)ÁÁÁF2 = 2.701(6) Å ].
Multiple p-p stacking interactions are observed between the pyridine rings with centroid-centroid distances in the range of 3.948(3)-5.508(4) Å , consequently building up columns of terpyridine ring systems along the [100] direction (Fig. S10) . Furthermore, Y-XÁÁÁp interactions are observed between Pd1-Cl1 and pyridine rings N2/C6-C10 and N3/ C11-C15 (Y(-X)ÁÁÁcentroid = 3.745(3) Å and 3.495(3) Å , respectively), and between C21 and O3 and pyridine ring N2/C6-C10 [3.472(5) Å ]. In fact, layers containing terpyridine and carboxypentoxy moieties are observed parallel with the (001) plane (Fig. S11) .
Compound 3 crystallized in the triclinic space group P-1, with the asymmetric unit consisting of one [PdCl(L3)]
? complex cationand one BF 4 -counterion. Analogous to 2, the Pd(II) atom is four-coordinated by the nitrogen atoms of the tridentate chelating L3 ligand and a chloride ion, showing a square-planar geometry (Fig. 4) . Here, the terpyridine ring system is slightly less planar than in 2, i.e. the dihedral angle between planes through the respective outer pyridine rings N2/C6-C10 and N3/C11-C15 is 5.5(2)°, and the dihedral angles between the outer rings and central pyridine ring N1/C1-C5 are 3.1(2)°and 6.9(2)°, respectively. Analogous to 2, the Pd-N bond distance to the central nitrogen atom [Pd1-N1 = 1.928(4) Å ] is slightly shorter than to the two outer nitrogen atoms [Pd1-N2 = 2.031(4) Å and Pd1-N3 = 2.037 (3) ? complex cations, one BF 4 -and one Cl -counterions in the asymmetric unit.
Analogous to 2 and 3, the Pt(II) atoms in both molecules are four-coordinated by the nitrogen atoms of the tridentate chelating L2 ligand and a chloride ion, showing a square-planar geometry (Fig. 5) . The dihedral angle between planes through the respective outer pyridine rings of both molecules is 1.6(3)°and 1.7(4)°, respectively, while the dihedral angles between the outer rings and central pyridine ring are 4.1(3)°and 3.0(3)°for the first molecule and 2.5(4)°a nd 1.3(3)°for the second molecule. The Pt-N bond distances to the central nitrogen atom (Pt1-N1 = 1.932(5) Å ; Pt2-N4 = 1.938(6) Å ) are again slightly shorter than to the two outer nitrogen atoms (Pt1-N2 = 2.021(5) Å , Pt1-N3 = 2.020(4) Å ; Pt2-N5 = 2.009(6) Å , Pt2-N6 = 2.015(6) Å ).
Analogous to the former structures of 2 and 3, the bond angles N2-Pt1-N1 (80.8(2)°), N3-Pt1-N1 (81.2(2)°) and N2-Pt1-N3 (161.9(2)°) for the first molecule and N5-Pt2-N4 (81.0(2)°), N6-Pt2-N4 (81.3(2)°) and N5-Pt2-N6 (162.3(3)°) for the second molecule deviate again from ideal values. Compared to 2, the carboxypentoxy chains of both molecules are not planar with respect to their terpyridine ring systems, mainly because of the O1-C16-C17-C18 torsion angle (60.8(7)°) and O4-C37-C38-C39 Fig. 4 Asymmetric unit of 3, showing thermal displacement ellipsoids at the 50% probability level and atom-labeling scheme of the non-hydrogen atoms (Fig. S13) .
Furthermore, Y-XÁÁÁp interactions are observed between Pt1-Cl1, Pt2-Cl2 and central pyridine rings N1/C1-C5, N4/C22-C26, respectively (Y(-X)ÁÁÁcen-troid = 3.629(3)Å and 3.639(3)Å , respectively).
Reactions with model proteins
The interactions of the five compounds with the selected model proteins i.e. HEWL, cyt c and RNase A were subsequently monitored through ESI-MS analysis. ESI-MS spectra, turned out particularly informative in determining the final metal to protein stoichiometry and the nature of protein bound metallic fragments. The results are summarized in Fig. 6 (interaction with RNase A) and in the SI (interaction with HEWL and cyt c). It is evident that none of the compounds showed reactivity towards HEWL (Fig. S14) . A limited reactivity of palladium-based compounds is observed by inspection of ESI-MS spectra. Only in the case of RNase A incubated with compounds 2 and 3, small amounts of metal-protein adducts have been detected. The metallic fragments bound to RNase A consist of the [Pd(II)L] 2? moiety for compound 2 (Fig. 6b) and with L losing the bromide for compound 3 (Fig. 6c) . In contrast, the platinum-based complexes (compound 4 and 5) showed an evident reactivity toward RNase A and a modest reactivity toward cyt c. In the latter case only mono-and bi-metalated derivatives are formed (Fig. S15) , while in the case of RNase A also triand tetra-metalated derivatives have been detected (Fig. 6) . Taking in account that hydrolysis of the PdCl bond plays an important role in the process of the reaction of this type of complexes towards biomolecules, high stability of this bond in the ammoniumacetate buffer could be a reason for the lower reactivity of the palladium complexes in reaction with the proteins (Shoukry et al. 1998; Wimmer and Wimmer 1998) .
Antiproliferative properties
The antiproliferative properties of compounds 1-5 were assessed against a small panel of human cancer cell lines (A549, HCT116 and IGROV-1) as well as against one normal cell line (HDF). M (with a metal complex to protein molar ratio of 3:1) Fig. 5 Asymmetric unit of 5, showing thermal displacement ellipsoids at the 50% probability level and atom-labeling scheme of the non-hydrogen atoms Fig. 6 continued determined according to the method described in the experimental section.
It is evident that palladium-based compounds (1, 2 and 3) and the platinum compound 5 showed similar cytotoxicity over all the cancer cell lines as well as on the normal one, while the platinum-based compound 4 exhibited lower IC 50 values for all the tumor cell lines compared to normal cells (Table 1) . Good selectivity of 4 towards cancer cell in comparison with normal cell may be the consequence of a different cellular uptake. We stress that human cancer cell lines (A549, IGROV1 and HCT-116) were (highly)sensitive to the treatment with 1-5 in the comparison with literature data related to cisplatin (IC 50 = 42 lM for A549, IC 50 = 21 lM for IGROV1 and IC 50 = 23 lM for HCT-116) (Seliman et al. 2018; Serova et al. 2005; Cirri et al. 2017 ).
Conclusions
The syntheses of five novel complexes of palladium(II) and platinum(II) with 2,2 0 :6 0 ,2 00 -terpyridine (terpy) derivatives modified at the 4 0 position have ). The limited reactivity of the palladium complexes (1, 2 and 3) towards the selected proteins indicates a potentially different mode of action of the Pd complexes in comparison with Pt complexes (4 and 5). Overall, the obtained results support the hypothesis that terpyridine Pt/Pd complexes possess interesting biological activity and are worthy of further, more detailed investigations, especially with the goal of determining their precise mode of action.
